BSE - Delayed Quote INR

ANG Lifesciences India Limited (ANG.BO)

29.77
+0.58
+(1.99%)
At close: 3:15:01 PM GMT+5:30
Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,075,792
1,460,089
2,197,783
3,541,245
1,539,033.15
Cost of Revenue
697,601
951,128
1,505,897
2,279,821
1,039,605.26
Gross Profit
378,191
508,961
691,886
1,261,424
499,427.90
Operating Expense
416,789
481,644
623,796
625,177
357,939.53
Operating Income
-38,598
27,317
68,090
636,247
141,488.37
Net Non Operating Interest Income Expense
-105,430
-108,805
-118,387
-91,344
-32,415.04
Pretax Income
-158,738
-107,135
26,250
535,005
101,390.76
Tax Provision
-11,338
-5,705
28,872
131,840
31,114.46
Net Income Common Stockholders
-147,399
-101,429
-2,622
403,165
70,276.31
Diluted NI Available to Com Stockholders
-147,399
-101,429
-2,622
403,165
70,276.31
Basic EPS
-10.81
-7.81
-0.20
38.89
5.42
Diluted EPS
-10.81
-7.81
-0.20
38.89
5.42
Basic Average Shares
12,845.55
12,991.99
13,058.29
10,366.63
12,958.29
Diluted Average Shares
13,058.29
12,991.99
13,058.29
10,366.63
12,958.29
Rent Expense Supplemental
--
3,247
3,612
1,864
2,495.73
Total Expenses
1,114,390
1,432,772
2,129,693
2,904,998
1,397,544.79
Net Income from Continuing & Discontinued Operation
-147,399
-101,429
-2,622
403,165
70,276.31
Normalized Income
-124,492.93
-78,074.59
-1,701.50
413,962.94
78,070.85
Interest Income
--
5,277
6,421
2,874
1,995.77
Interest Expense
99,848
103,223
111,925
82,795
30,734.08
Net Interest Income
-105,430
-108,805
-118,387
-91,344
-32,415.04
EBIT
-58,890
-3,912
138,175
617,800
132,124.84
EBITDA
14,471
79,802
231,710
676,552
145,293.15
Reconciled Cost of Revenue
697,601
951,128
1,505,897
2,279,821
1,039,605.26
Reconciled Depreciation
73,361
83,714
93,535
58,752
13,168.30
Net Income from Continuing Operation Net Minority Interest
-147,399
-101,429
-2,622
403,165
70,276.31
Total Unusual Items Excluding Goodwill
-24,668
-24,668
-1,315
-14,329
-11,245.54
Total Unusual Items
-24,668
-24,668
-1,315
-14,329
-11,245.54
Normalized EBITDA
39,139
104,470
233,025
690,881
156,538.69
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,761.93
-1,313.59
-394.50
-3,531.06
-3,450.99
3/31/2021 - 12/30/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade